TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,720 | -66.3% | 2,000 | 0.0% | 0.01% | -62.5% |
| Q2 2023 | $49,680 | +65.2% | 2,000 | 0.0% | 0.02% | +45.5% |
| Q1 2023 | $30,080 | +154.1% | 2,000 | 0.0% | 0.01% | +83.3% |
| Q4 2022 | $11,840 | -1.3% | 2,000 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $12,000 | +33.3% | 2,000 | 0.0% | 0.01% | +20.0% |
| Q2 2022 | $9,000 | -52.6% | 2,000 | 0.0% | 0.01% | -44.4% |
| Q1 2022 | $19,000 | -50.0% | 2,000 | 0.0% | 0.01% | -52.6% |
| Q4 2021 | $38,000 | -43.3% | 2,000 | 0.0% | 0.02% | -50.0% |
| Q3 2021 | $67,000 | -4.3% | 2,000 | 0.0% | 0.04% | -2.6% |
| Q2 2021 | $70,000 | -27.1% | 2,000 | 0.0% | 0.04% | -38.1% |
| Q1 2021 | $96,000 | -7.7% | 2,000 | 0.0% | 0.06% | -18.2% |
| Q4 2020 | $104,000 | +395.2% | 2,000 | 0.0% | 0.08% | +250.0% |
| Q1 2020 | $21,000 | – | 2,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |